comparemela.com

Page 11 - Inphi Corporation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

SHAREHOLDER ALERT: WeissLaw LLP Reminds EIDX, IPHI, ALXN, and XLNX Shareholders About Its Ongoing Investigations

Eidos Therapeutics, Inc. (NASDAQ: EIDX) WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Eidos Therapeutics, Inc. (NASDAQ: EIDX) in connection with the proposed interested-party acquisition of the company by BridgeBio Pharma, Inc. ( BridgeBio ).  Under the terms of the agreement, EIDX shareholders can elect to receive either 1.85 shares of BridgeBio or $73.26 for each share of EIDX share they own, subject to proration such that the aggregate cash portion will not exceed $175 million.    If you own EIDX shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website:  https://weisslawllp.com/eidx/

SHAREHOLDER ALERT: Rigrodsky & Long, P A Reminds Investors of Investigation of Inphi

Press release content from Globe Newswire. The AP news staff was not involved in its creation. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigation of Inphi . Rigrodsky & Long, P.A.December 30, 2020 GMT WILMINGTON, Del., Dec. 30, 2020 (GLOBE NEWSWIRE) Rigrodsky & Long, P.A. announces that it is investigating Inphi Corporation (“Inphi”) (NASDAQ GS: IPHI ) regarding possible breaches of fiduciary duties and other violations of law related to Inphi’s agreement to be acquired by Marvell Technology Group Ltd. (“Marvell”) (NASDAQ GS: MRVL ). Under the terms of the agreement, Inphi’s shareholders will receive 2.323 shares of Marvell and $66.00 in cash per share.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.